Latest Patent Grant Is Driving VYNE Therapeutics Stock Higher Today

VYNE Therapeutics Inc. (NASDAQ: VYNE) is seeing a significant boost in the price of its stock today. As of the last check during current session, VYNE stock was up 11.11% to $2.50. A notable developments in VYNE’s portfolio of intellectual property is the driving force behind that surge. Announcement of Patent Grant VYNE Therapeutics unveiled […]